NO20020792L - Behandling av rastlöse ben syndrom med en kombinasjon av clonidin og opioid - Google Patents

Behandling av rastlöse ben syndrom med en kombinasjon av clonidin og opioid

Info

Publication number
NO20020792L
NO20020792L NO20020792A NO20020792A NO20020792L NO 20020792 L NO20020792 L NO 20020792L NO 20020792 A NO20020792 A NO 20020792A NO 20020792 A NO20020792 A NO 20020792A NO 20020792 L NO20020792 L NO 20020792L
Authority
NO
Norway
Prior art keywords
combination
treatment
clonidine
opioid
restless leg
Prior art date
Application number
NO20020792A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020792D0 (no
Inventor
Hans-Michael Brecht
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20020792D0 publication Critical patent/NO20020792D0/no
Publication of NO20020792L publication Critical patent/NO20020792L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20020792A 1999-08-19 2002-02-18 Behandling av rastlöse ben syndrom med en kombinasjon av clonidin og opioid NO20020792L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19938823A DE19938823A1 (de) 1999-08-19 1999-08-19 Medikamentöse Behandlung des Restless Leg Syndroms
PCT/EP2000/007719 WO2001013903A2 (fr) 1999-08-19 2000-08-09 Traitement therapeutique du syndrome des jambes sans repos

Publications (2)

Publication Number Publication Date
NO20020792D0 NO20020792D0 (no) 2002-02-18
NO20020792L true NO20020792L (no) 2002-02-18

Family

ID=7918572

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020792A NO20020792L (no) 1999-08-19 2002-02-18 Behandling av rastlöse ben syndrom med en kombinasjon av clonidin og opioid

Country Status (21)

Country Link
US (1) US20010053777A1 (fr)
EP (1) EP1210076A2 (fr)
JP (1) JP2003513014A (fr)
KR (1) KR20020020273A (fr)
CN (1) CN1368878A (fr)
AR (1) AR025329A1 (fr)
AU (1) AU6836500A (fr)
BR (1) BR0013355A (fr)
CA (1) CA2382648A1 (fr)
CO (1) CO5190708A1 (fr)
CZ (1) CZ2002516A3 (fr)
DE (1) DE19938823A1 (fr)
IL (1) IL147643A0 (fr)
MX (1) MXPA02001295A (fr)
NO (1) NO20020792L (fr)
PE (1) PE20010738A1 (fr)
PL (1) PL364871A1 (fr)
SK (1) SK2452002A3 (fr)
TR (1) TR200200450T2 (fr)
UY (1) UY26296A1 (fr)
WO (1) WO2001013903A2 (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2314893C (fr) 1997-12-22 2005-09-13 Euro-Celtique, S.A. Combinaison d'agonistes et d'antagonistes d'opioides
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
NZ522112A (en) * 2000-04-21 2004-10-29 Upjohn Co Substituted phenylazacycloalkane-type compounds for treating fibromyalgia and chronic fatigue syndrome
KR20020089510A (ko) * 2000-04-21 2002-11-29 파마시아 앤드 업존 캄파니 섬유 근육통 증후군 및 만성 피로 증후군의 치료
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10041479A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
AR031152A1 (es) * 2000-10-31 2003-09-10 Upjohn Co Tratamientos nuevos para el sindrome de piernas inquietas
PT1380306E (pt) 2001-03-30 2009-05-25 Toray Industries Medicamentos para psiconeurose
WO2002083141A1 (fr) * 2001-04-17 2002-10-24 Pharmacia & Upjohn Company Traitement de la fibromyalgie et du syndrome de la fatigue chronique
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
US20030073609A1 (en) * 2001-06-29 2003-04-17 Pinkerton Thomas C. Enhanced pharmacokinetic profile of intradermally delivered substances
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20060263419A1 (en) * 2002-03-12 2006-11-23 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
EP1492506B2 (fr) * 2002-04-05 2016-06-29 Euro-Celtique S.A. Matrice pour liberation prolongee, constante et independante de composes actifs
DE10220230A1 (de) * 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
PL372695A1 (en) * 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
US8246980B2 (en) * 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system
DK1426049T3 (da) 2002-12-02 2005-08-22 Sanol Arznei Schwarz Gmbh Iontophoretisk tilförsel af rotigotin til behandling af Parkinsons sygdom
DE10338174A1 (de) 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
EP1604667A1 (fr) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement des impatiences des membres inférieurs
EP1604666A1 (fr) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioides pour le traitement de la bronchopneumopathie chronique obstructive
AU2006208627B8 (en) * 2005-01-28 2009-08-13 Mundipharma Pty Limited Alcohol resistant dosage forms
EP1695700A1 (fr) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Forme posologique contenant de l'oxycodone et de la naloxone
EP1702558A1 (fr) 2005-02-28 2006-09-20 Euro-Celtique S.A. Procédé et dispositif pour évaluer la fonction de l'activité intestinale
EP1813276A1 (fr) * 2006-01-27 2007-08-01 Euro-Celtique S.A. Formes de dosage inviolables
NZ571591A (en) 2006-04-03 2011-09-30 Teva Pharma Use of rasagiline for the treatment of restless legs syndrome
US20100029618A1 (en) * 2006-12-22 2010-02-04 Gil Daniel W Alpha-2 receptor pan agonist and anticonvulsant compositions for treating chronic pain
WO2009158477A1 (fr) * 2008-06-25 2009-12-30 Us Worldmeds Llc Timbres transdermiques et formulations à libération prolongée comprenant de la lofexidine pour administration par voie transdermique et orale
MX347106B (es) 2009-03-10 2017-04-12 Euro-Celtique S A * Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
US20180264013A1 (en) * 2010-07-08 2018-09-20 Wellesley Pharmaceuticals, Llc Composition and methods for treating sleep disorders
CA2876203A1 (fr) * 2012-06-11 2013-12-19 Psychogenics, Inc. Utilisation de l'eltoprazine dans le traitement des troubles moteurs et du mouvement associes aux traitements antiparkinsoniens
CA2918004C (fr) 2013-07-23 2018-11-20 Euro-Celtique S.A. Combinaison d'oxycodone et de naloxone pour utilisation dans le traitement de la douleur chez des patients souffrant de douleur et d'une maladie entrainant une dysbiose intestinale et/ou l'augmentation du risque de translocation bacterienne intestinale
KR101827980B1 (ko) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
ES2847936T3 (es) 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina
KR101831290B1 (ko) 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
EP3512600A4 (fr) * 2016-09-13 2020-05-27 Mindlab LLC Combinaisons de médicaments et traitement du syndrome des jambes sans repos
LT3906927T (lt) * 2020-05-04 2022-08-10 Bioprojet Pharma Dalinių dopamino d3 agonistų naudojimas centrinės nervų sistemos sutrikimams gydyti
CN115154448B (zh) * 2022-08-04 2024-01-30 谭竞 一种治疗不宁腿综合征的药物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859685A (en) * 1986-08-13 1989-08-22 Boc, Inc. Anesthetic composition and method of using the same
DE19749724A1 (de) * 1997-11-11 1999-06-10 Gruenenthal Gmbh Verwendung einer Kombination aus Opioid und alpha-adrenergem Agonisten in Schmerzmitteln
SE9803760D0 (sv) * 1998-11-04 1998-11-04 Jan Hedner Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
WO2000054773A1 (fr) * 1999-03-12 2000-09-21 Nitromed, Inc. Agonistes dopaminergiques en combinaison avec des donneurs d'oxyde nitrique, compositions et methodes d'utilisation

Also Published As

Publication number Publication date
AU6836500A (en) 2001-03-19
JP2003513014A (ja) 2003-04-08
CZ2002516A3 (cs) 2002-05-15
CA2382648A1 (fr) 2001-03-01
CN1368878A (zh) 2002-09-11
EP1210076A2 (fr) 2002-06-05
SK2452002A3 (en) 2002-06-04
PL364871A1 (en) 2004-12-27
US20010053777A1 (en) 2001-12-20
DE19938823A1 (de) 2001-02-22
AR025329A1 (es) 2002-11-20
IL147643A0 (en) 2002-08-14
PE20010738A1 (es) 2001-07-16
CO5190708A1 (es) 2002-08-29
TR200200450T2 (tr) 2002-08-21
BR0013355A (pt) 2002-04-30
NO20020792D0 (no) 2002-02-18
UY26296A1 (es) 2001-04-30
MXPA02001295A (es) 2002-08-12
KR20020020273A (ko) 2002-03-14
WO2001013903A3 (fr) 2001-08-23
WO2001013903A2 (fr) 2001-03-01

Similar Documents

Publication Publication Date Title
NO20020792L (no) Behandling av rastlöse ben syndrom med en kombinasjon av clonidin og opioid
DE60335294D1 (de) Dlung des extrapyramidalen syndroms
MXPA03003912A (es) Tratamientos nuevos para el sindrome de piernas inquietas.
MXPA05002942A (es) Forma de dosificacion oral de liberacion modificada.
PT1333887E (pt) Metodo de tratamento de desordens musculares
NO20003233D0 (no) 4-hydrokykinolin-3-karboksamider og hydraziner som antivirale midler
MXPA04008772A (es) Composiciones de clorhidrato de naltrexona.
HUP0401740A2 (hu) N-szubsztituált hidroxipirimidinon-karboxamid HIV-integráz inhibitorok és ezeket tartalmazó gyógyszerkészítmények
NO20062677L (no) Benzyleteraminforbindelser anvendbare som CCR-5-antagonister
ECSP055701A (es) Nuevos derivados de pirimidinamida y el uso de los mismos
NO20035025L (no) Anvendelse av osteopontin for behandling og/eller for a hindre nevrologiske sykdommer, samt farmasoytisk sammensetning omfattende osteopontin eller en antagonist med osteopontinaktivitet.
DE60322423D1 (de) Pyrrolidin- und azetidinverbindungen alsccr5-antagonisten
NO20020793L (no) Virkestoffkombinasjon med clonidin
DK1501499T3 (da) Transepikutan indgivelsesform til behandling af restless legs-syndromet
NO20061575L (no) Fremgangsmate for fremstilling av renzapride og mellomprodukter derav
DE60324014D1 (de) Heterocyclische verbindungen alsccr5-antagonisten
HUP9800938A2 (hu) NK-1 receptor antagonisták alkalmazása irritációs bélszindróma tüneteinek kezelésére
SE9803760D0 (sv) Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
NO20014855L (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
CY1107062T1 (el) ΧΡΗΣΗ ΔΡΑΣΤΙΚΩΝ ΟΥΣΙΩΝ ΜΕ ΔΡΑΣΗ ΑΓΩΝΙΣΤΗ μ-ΥΠΟΔΟΧΕΑ ΟΠΙΟΕΙΔΩΝ ΚΑΙ ΔΡΑΣΗ ΑΝΤΑΓΩΝΙΣΤΗ ΥΠΟΔΟΧΕΑ ΟΠΙΟΕΙΔΩΝ ΩΣ ΦΑΡΜΑΚΕΥΤΙΚΑ ΜΕΣΑ ΣΥΝΔΥΑΣΜΟΥ ΓΙΑ ΤΗΝ ΑΝΤΙΜΕΤΩΠΙΣΗ ΤΟΥ ΚΑΡΚΙΝΟΥ
MY128529A (en) Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
MXPA04002539A (es) Combatientes de los receptores de la acetilcolina nicotinica en el tratamiento del sindrome de pierna inquietas.
WO2004019881A3 (fr) Administration d'hypocretine comme traitement contre l'obesite
ATE337704T1 (de) Zusammensetzungen mit biostimulierender wirksamkeit
EP1260221A3 (fr) Therapie de combinaison de la depression et de l'anxieté

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application